You are in Press Releases Claron Receives FDA 510k Clearance for NilRead Diagnostic Zero-Footprint Medical Image Viewer

Claron Receives FDA 510k Clearance for NilRead Diagnostic Zero-Footprint Medical Image Viewer

E-mail Print PDF


physiciansOctober 21, 2013, Toronto—Claron Technology, a leader in the medical imaging web revolution, announces U.S. Food and Drug Administration (FDA) 510k clearance of NilRead zero-footprint viewer for the diagnostic interpretation of medical images.

NilRead is the first universal, web-based zero-footprint viewer supporting multi-monitor configurations.

A full-featured medical imaging viewer, NilRead enables diagnostic interpretation of medical images and related digital information on a variety of computers anytime, anywhere across the enterprise and beyond.

It supports diagnostic viewing of all cleared DICOM imaging modalities on single or multi-monitor configurations.

Running from a remote server, the innovative viewer supports viewing of high-resolution, diagnostic quality medical images and data formats with no software download and no compromise on performance.

The advanced viewer features customizable hanging protocols, prior-current comparison and extensive measurements.

Its advanced visualization features include thin/thick slabs, MIP, volume rendering, PET/CT fusion, and more.

It delivers the highest levels of security and leaves no information on the viewing hardware when the session is complete.

“I have participated in the Claron Technology Clinical Study to assess NilRead image quality on a number of devices reviewing over 160 studies,” says Dr. Stephen Florence, Managing Partner, Credit Valley Imaging Associates and Adjunct Lecturer, Department of Medical Imaging, University of Toronto.

“In addition to confirming the high quality display quality of NilRead, I have been able to quickly and effectively use the software on multiple devices with minimal instructions.

I really appreciated the simplicity of the software, its usability and consistent graphical user interface across all the devices.

I believe NilRead is going to be a very useful tool for web-based diagnostic reads both inside and outside the hospital.”

“We are thrilled to extend our Nil family with the option of a web-based FDA-cleared diagnostic viewer available to all our partners,” says Claudio Gatti, Co-CEO and Co-Founder of Claron Technology.

“Our Nil family of enterprise viewers, which is in daily use at hundreds of health care facilities, has been helping our partners to meet their clinical needs since 2010.

We expect the diagnostic clearance of NilRead will allow our partners to extend the efficiency of our zero-footprint solution to meet their diagnostic needs.

We are extremely pleased to be in the forefront of web enabled diagnostic technology with the FDA clearance of NilRead.”

About Claron Technology, Inc

Claron is dedicated to the application of image processing, image sharing and image distribution in medicine.

It has extensive experience in developing systems that help clinicians identify anatomy and tissues of interest, visualize and analyze them, and securely distribute them on a variety of different platforms from desktop to smartphones.

Claron helps healthcare providers deliver more value to their patients by making physicians more efficient and connected.

These signals are relayed buying clomid online safe which then is by a number of such as medial preoptic and paraventricular nulcei.